Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients

BACKGROUND: Immunotherapy has revolutionized the clinical outcomes of intractable cancer patients. Little is known about the intestinal nonpathogenic bacterial composition of hepatocellular carcinoma (HCC) patients treated by immunotherapy. AIM: To determine whether there is a correlation between gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Min-Woo, Kim, Moon-Ju, Won, Eun Jeong, Lee, Yu Jeong, Yun, Yong-Woon, Cho, Sung Bum, Joo, Young-Eun, Hwang, Jun-Eul, Bae, Woo Kyun, Chung, Ik-Joo, Shin, Myung Geun, Shin, Jong Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611200/
https://www.ncbi.nlm.nih.gov/pubmed/34876793
http://dx.doi.org/10.3748/wjg.v27.i42.7340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611200/
https://www.ncbi.nlm.nih.gov/pubmed/34876793
http://dx.doi.org/10.3748/wjg.v27.i42.7340

Ejemplares similares